<!DOCTYPE html>
<html lang="en">
  <head>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link
      href="https://fonts.googleapis.com/css2?family=EB+Garamond:wght@400;700&display=swap"
      rel="stylesheet"
    />
    <meta charset="UTF-8" />
    <title>Alice Ji ‚Äì Portfolio</title>
    <meta
      name="description"
      content="Portfolio of Alice Ji. A showcase of projects bridging research and industry applications."
    />
    <meta name="viewport" content="width=device-width,initial-scale=1" />
    <link rel="stylesheet" href="../styles.css" />
    <link
      rel="icon"
      href="assets/favicon.png"
      type="image/png"
    />
  </head>
  <body>
    <nav class="navbar">
      <a href="../index.html">
        <img
          src="https://alice-ji.github.io/portfolio/assets/favicon.png"
          style="width: 24px; height: 24px;"
        />
      </a>
      <a href="../index.html" class="nav-link">Home</a>
      <button id="dark-toggle" class="dark-toggle">üåí Dark Mode</button>
    </nav>

    <a href="../index.html" id="back-btn" title="Back to portfolio">
      &#8678; Back
    </a>
    
    <main>
        <section class="case-study">

            <header class="case-header">
              <figure>
                <img
                  src="https://alice-ji.github.io/portfolio/assets/pharmaad-card.png"
                />
              </figure>    
          
              <h1>Reimagining Risk Disclosure in Social Media Pharmaceutical Advertising</h1>
          
              <p class="subtitle">
                Product-facing UX research translating regulatory requirements 
                <br>
                into usable, patient-centered safety communication.
              </p>
          
              <div class="case-meta">
                <p><strong>Role:</strong> Lead UX Researcher (User Attention & Comprehension)</p>
                <p><strong>Methods:</strong> Eye tracking, experimental design, telemetry analysis</p>
                <p><strong>Tools:</strong> Tobii eye tracker, iMotions, Qualtrics, R, Adobe Premiere, Figma, custom web prototypes</p>
                <p><strong>Focus:</strong> Risk communication, attention, informed decision-making</p>
                <p><strong>Stakeholders:</strong> Regulatory, Legal, Product, Marketing, UX</p>
                <p><strong>Outcome:</strong> Evidence-based design principles for safer pharma advertising UX</p>
              </div>
            </header>
          
            <section class="case-glance">
              <h2>At a Glance</h2>
              <ul>
                <li>Identified where regulatory-compliant designs fail real-world usability</li>
                <li>Translated attention and memory gaps into concrete UX risks</li>
                <li>Evaluated design tradeoffs between comprehension, engagement, and cognitive load</li>
                <li>Generated evidence to inform safer, condition-aware risk disclosure design</li>
              </ul>              
            </section>
          
            <section class="case-narrative">
              <h2>Problem Context</h2>
          
              <p>
                Pharmaceutical advertising on social media operates at the intersection of regulation,
                persuasion, and user experience. In 2014, the FDA issued guidance requiring that any
                benefit claim in a limited-space social media ad be accompanied by risk information that
                is equally clear and prominent.
              </p>
          
              <p>
                In practice, most ads technically comply but functionally fail.
                Benefits are presented through engaging narratives and visuals, while risks are relegated
                to dense, scrolling safety text that appears late in the ad.
              </p>
          
              <p>
                This creates a critical UX problem:
                <strong>Can users actually notice, process, and remember safety information well enough to
                make informed decisions?</strong>
              </p>
          
              <p>
                This project reframes pharmaceutical risk disclosure not as a legal checkbox, but as a
                usability and comprehension challenge with direct implications for patient autonomy,
                ethical persuasion, and regulatory trust.
              </p>

              <p>
                For product and policy teams, this gap represents a systemic UX risk:
                designs can meet regulatory standards while still failing user comprehension.
                This disconnect has downstream implications for patient trust, ethical persuasion,
                and long-term credibility of health communication platforms.
              </p>              
            </section>
          
            <section class="case-question">
              <h2>Research Question</h2>
              <p><em>Framed as a product and policy question:</em></p>              
              <p>
                How can social media pharmaceutical ads present risk information in a way that real users
                actually attend to, understand, and remember without increasing cognitive burden?
              </p>
              <ul>
                <li>Do users pay attention to risk information in current ad formats?</li>
                <li>How does attention map onto memory and health beliefs?</li>
                <li>Can UX interventions improve comprehension without changing regulated content?</li>
              </ul>
            </section>
          
            <section class="case-design">
              <h2>Study 1: Diagnostic UX Audit</h2>          
          
              <p>
                I led the user research component of a multi-institutional project by first diagnosing
                the problem. We conducted an in-person eye-tracking study to observe how users actually
                attend to benefit and risk information in real pharmaceutical ads.
              </p>

              <p>
                Fifty participants watched a diverse set of real social media pharma ads embedded within
                a simulated feed. We recorded gaze behavior frame-by-frame during benefit and risk
                segments, then assessed recall and health belief measures immediately after each ad.
              </p>
          
              <p>
                This phase functioned as a diagnostic UX audit, establishing baseline performance
                before proposing any design intervention.
                This approach allowed us to connect what users looked at with
                what they remembered and how they felt.
              </p>
            </section>
          
            <section class="case-methods">
              <h2>Methods & Measures</h2>
              <ul>
                <li><strong>Method:</strong> In-lab eye tracking</li>
                <li><strong>Sample:</strong> 50 adult participants</li>
                <li><strong>Stimuli:</strong> Real pharmaceutical social media ads across conditions</li>
                <li><strong>Measures:</strong> Gaze allocation, recall accuracy, health belief constructs
                  (severity, susceptibility, self-efficacy, cue to action)</li>
                <li><strong>Goal:</strong> Identify breakdowns in attention and comprehension</li>
              </ul>
              <figure>
                <img
                  src="https://alice-ji.github.io/portfolio/assets/pharmaad-procedure1.png"
                />
                <figcaption>
                    Study 1 Procedure
                  </figcaption>
              </figure> 
              
              <p>
                This mixed-methods approach allowed us to triangulate behavioral data,
                self-report measures, and downstream decision signals, mirroring how
                product teams evaluate UX effectiveness at scale.
                </p>

            </section>
          
            <section class="case-findings">
              <h2>Key UX Findings</h2>
          
              <h3>1. Risk information is remembered at half the rate of benefits</h3>
              <p>
                When collapsing across ads, participants recalled benefits with <strong>~64%</strong> accuracy.
                Risk recall, however, averaged only <strong>~33%</strong>.
              </p>
          
              <p>
                Despite regulatory requirements for balance, users walked away with a highly asymmetric
                understanding of benefits versus risks.
                From a product perspective, this represents a comprehension gap large enough
                to undermine the intent of balanced risk-benefit communication.
              </p>
          
              <h3>2. Attention collapses during scrolling safety text</h3>

              <figure>
                <video
                  src="https://alice-ji.github.io/portfolio/assets/isi-demo.mp4"
                  autoplay
                  loop
                  muted
                  playsinline
                ></video>
              </figure>            

              <p>
                Eye-tracking data showed that as soon as the risk segment began, visual attention scattered.
                Participants looked at UI chrome, unrelated visuals, and feed elements, anywhere but the
                scrolling safety text.
                In UX terms, the scrolling safety text functions as a low-salience, high-cost
                information channel that users actively disengage from.
              </p>
          
              <h3>3. Ads increase urgency even when risks are not retained</h3>

              <figure>
                <img
                  src="https://alice-ji.github.io/portfolio/assets/pharmaad-result-sussev.png"
                />
              </figure> 

              <p>
                Exposure increased perceived severity and susceptibility (key predictors of intent to
                consult a doctor) even when risk memory was poor.
              </p>
          
              <p>
                This raised a critical concern: urgency was increasing without corresponding understanding.
              </p>
            </section>
          
            <section class="case-design">
              <h2>Study 2: UX Redesign Experiment</h2>
          
              <p>
                Based on the diagnostic findings, I led the redesign phase focused on improving risk
                comprehension through interface-level interventions without altering regulated text.
              </p>

              <p>
                This phase reframed risk disclosure as a design experimentation problem,
                testing how alternative information architectures perform under real
                attentional constraints.
                    </p>
          
              <p>
                I introduced two design layers:
              </p>
          
              <ul>
                <li><strong>Graphic layer:</strong> Simple icons representing key side effects</li>
                <li><strong>Audio narration:</strong> Spoken delivery of the exact risk text</li>
              </ul>
          
              <p>
                These interventions were fully crossed, producing four ad variants:
                original, graphic-only, narration-only, and graphic + narration.
              </p>
              <figure>
                <img
                  src="https://alice-ji.github.io/portfolio/assets/pharmaad-stim2.png"
                />
              </figure> 
            </section>
          
            <section class="case-methods">
              <h2>Experimental Implementation</h2>
              <ul>
                <li><strong>Platform:</strong> Qualtrics with custom GitHub-hosted prototype</li>
                <li><strong>Sample:</strong> 200 participants (50 per condition)</li>
                <li><strong>Stimuli:</strong> Real ads sourced from Meta Ad Library, 
                    <br>Feed-based prototype mimicking real social media interaction for ecological validity</li>
                <li><strong>Telemetry:</strong> CTA clicks, hover behavior, UI interaction</li>
                <li><strong>Design:</strong> Between-subjects, randomized exposure</li>
              </ul>
              <figure>
                <img
                  src="https://alice-ji.github.io/portfolio/assets/pharmaad-procedure2.png"
                />
                <figcaption>
                    Study 2 Procedure
                  </figcaption>
              </figure>  
            </section>
          
            <section class="case-findings">
              <h2>Key Experimental Insights</h2>

              <figure>
                <img
                  src="https://alice-ji.github.io/portfolio/assets/pharmaad-result2.png"
                />
              </figure> 
          
              <h3>1. Single-channel cues outperform layered designs</h3>
              <p>
                Both graphic and narration interventions significantly improved risk recall
                (up to ~57%), compared to the control (~37%).
              </p>
          
              <p>
                Surprisingly, combining both cues performed worse than either alone, suggesting
                cognitive overload when multiple channels compete.
                This highlights a critical UX tradeoff: adding information can improve recall
                up to a point, after which cognitive load erodes effectiveness.
              </p>
          
              <h3>2. UX effectiveness varies by condition context</h3>
              <p>
                Telemetry revealed divergent click behavior across drug categories.
                For ADHD medications, added risk cues reduced engagement.
                For depression medications, the same cues increased engagement.
              </p>
          
              <p>
                These findings suggest that risk disclosure UX must be condition-aware rather
                than universally standardized.
              </p>
            </section>
          
            <section class="case-interpretation">
              <h2>Interpretation</h2>
              <p>
                Compliance alone does not guarantee comprehension.
                Risk disclosures fail when they are treated as legal artifacts rather than user-facing
                information systems.
              </p>
          
              <p>
                Effective risk communication depends on attentional bandwidth, emotional context,
                and cognitive load, not just visibility.
              </p>
            </section>
          
            <section class="case-implications">
              <h2>Product & Policy Implications</h2>
              <ul>
                <li>Treat risk disclosures as first-class UX components</li>
                <li>Prioritize clarity over redundancy in safety communication</li>
                <li>Design condition-aware risk presentation strategies</li>
                <li>Evaluate comprehension, not just exposure metrics</li>
                <li>Integrate usability testing into regulatory compliance workflows</li>
              </ul>
            </section>
          
            <section class="case-conclusion">
              <h2>Why This Matters</h2>
              <p>
                Social media pharmaceutical ads shape health decisions for millions of users.
                If safety information is not usable, compliance becomes performative rather than protective.
              </p>
          
              <p>
                This project demonstrates how UX research can bridge regulation, ethics, and real-world
                decision-making by ensuring that critical information is not just present, but understood.
                For organizations operating in regulated spaces, this work illustrates how
                UX research can reduce ethical risk, improve decision quality, and strengthen
                long-term user trust without compromising compliance.
              </p>
            </section>
          
          </section>


      <section class="contact-section">
        <a href="mailto:rji3@illinois.edu" class="contact-email"
          >rji3@illinois.edu</a
        >
        <div class="social-links">
          <a
            href="https://www.linkedin.com/in/alice-ji-8a4b2a161/"
            target="_blank"
          >
            <img
              src="https://alice-ji.github.io/portfolio/assets/LinkedIn.png"
              alt="LinkedIn"
              title="LinkedIn"
            />
          </a>
          <a
            href="https://scholar.google.com/citations?hl=en&user=CVlgqCAAAAAJ"
            target="_blank"
          >
            <img
              src="https://alice-ji.github.io/portfolio/assets/GoogleScholarLogo.png"
              alt="Google Scholar"
              title="Google Scholar"
            />
          </a>
          <a href="https://github.com/Alice-Ji" target="_blank">
            <img
              src="https://alice-ji.github.io/portfolio/assets/github.png"
              alt="Github"
              title="Github"
            />
          </a>
          <a href="https://medium.com/@alice-ji" target="_blank">
            <img
              src="https://alice-ji.github.io/portfolio/assets/medium.png"
              alt="Medium"
              title="Medium"
            />
          <a href="https://madlabresearch.web.illinois.edu/" target="_blank">
            <img
              src="https://alice-ji.github.io/portfolio/assets/madlab.png"
              alt="MadLab"
              title="MadLab"
            />
          </a>
        </div>
      </section>
    </main>

    <footer>&copy; 2026 Alice Ji</footer>

    <script>
      const btn = document.getElementById("dark-toggle");
      if (localStorage.getItem("dark-mode") === "true") {
        document.body.classList.add("dark-mode");
        btn.textContent = "‚òÄÔ∏è Light Mode";
      }
      btn.onclick = () => {
        document.body.classList.toggle("dark-mode");
        const enabled = document.body.classList.contains("dark-mode");
        btn.textContent = enabled ? "‚òÄÔ∏è Light Mode" : "üåí Dark Mode";
        localStorage.setItem("dark-mode", enabled);
      };
    </script>
  </body>
</html>
